Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A phase 3 study to evaluate efficacy and safety of AGSAVI
Epistemonikos ID: 67938001929ee90152cc61218d61629134e78e71
First added on: May 08, 2024